Onefund, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Onefund, LLC
- $98.5 Billion
- Q3 2024
A detailed history of Onefund, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Onefund, LLC holds 278 shares of REGN stock, worth $223,603. This represents 0.3% of its overall portfolio holdings.
Number of Shares
278
Previous 276
0.72%
Holding current value
$223,603
Previous $290 Million
0.74%
% of portfolio
0.3%
Previous 0.32%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,512Shares Held
84.5MCall Options Held
926KPut Options Held
1.22M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.5 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.79 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$6.02 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.94 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.46 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $86.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...